KHRNF - Khiron Life Sciences Corp.
| Previous Close | 1.4600 |
| Open | 1.4650 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 1.4357 - 1.5300 |
| 52 Week Range | 0.6837 - 3.2800 |
| Volume | 67,483 |
| Avg. Volume | 153,064 |
| Market Cap | 161.552M |
| Beta (3Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3020 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire
Khiron Provides Clarification of August 12, 2019 News Release
TORONTO, Aug. 14, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, wishes to clarify specific disclosure relating to the news release disseminated by the Company on August 12, 2019. Khiron Life Sciences Corp. is positioned to be the dominant integrated cannabis company in Latin America. Khiron has core operations in Latin America and is fully licensed in Colombia for the cultivation, production, domestic distribution, and international export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis.
- PR Newswire
Khiron Boosts European Expansion With Key Executive Appointments
Experienced capital markets leader and cannabis industry executive Tejinder Virk is appointed President of Khiron Europe Accomplished cannabis legal expert Franziska Katterbach joins Company as Chief Legal ...
- CNW Group
Khiron Launches Revenue-Generating Pilot Program With Top Colombian Health Insurance Provider
Khiron Launches Revenue-Generating Pilot Program With Top Colombian Health Insurance Provider
- CNW Group
Khiron Signs Kuida Distribution Agreement with Grupo Éxito, South America's Market Leading Retail Group
Grupo Éxito has a multinational retail presence in Colombia , Brazil , Argentina and Uruguay and operates 1,533 stores. Kuida to be introduced as key addition to the retailer's cosmetics products category, with experience centres and consultants in each Éxito WOW store to support sales and brand awareness.
CNW GroupKhiron and Dixie Receive Conditional TSXV Approval for Roll-Out of Kuida Cosmeceutical Line in U.S. Market and Cannabis-Infused Products in Latin America
Khiron and Dixie Receive Conditional TSXV Approval for Roll-Out of Kuida Cosmeceutical Line in U.S. Market and Cannabis-Infused Products in Latin America
- CNW Group
Khiron Provides Update on Canapalife Group Transaction
TORONTO , Aug. 1, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated cannabis company with core operations in Latin America, today provided an update on the Company's previously announced non-binding LOI with Canapalife Group. The Company confirms the expiry of the LOI and that the parties have mutually agreed not to proceed with the proposed transaction. Khiron Life Sciences Corp. is positioned to be the dominant integrated cannabis company in Latin America.
- PR Newswire
Khiron Begins Pre-clinical Medical Cannabis Studies with Leading Academic Institutes in Uruguay
Patient-focused studies advance progress towards global clinical trials on Khiron strains to treat inflammation, oxidative and nervous system disorders Co-sponsored with Uruguay government using Company ...
- CNW Group
Khiron Announces Final Approval of Acquisition of NettaGrowth
Khiron Announces Final Approval of Acquisition of NettaGrowth
- PR Newswire
Khiron Life Sciences Added to NYSE-Listed The Cannabis ETF
TORONTO, July 25, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, announced today that it has been added to The Cannabis ETF (NYSE:THCX) ("THCX"), which trades on the New York Stock Exchange. Khiron Life Sciences Corp. is positioned to be the dominant integrated cannabis company in Latin America.
- Benzinga
From Coffee To Cannabis: Colombia's Choice Between Economic Development And 'CannaMercantilism'
This is the second of a two-part series on the history of Colombia’s troubled past and how it has informed its route to cannabis legalization. Mr. Azadian replied, “We were frustrated with many things in the marketplace including product inconsistency, quality control standards, inefficiencies, high costs of products and environmentally unsustainable operations.
- CNW Group
Khiron Obtains Final Approval to Commercialize CBD Production and Receives Approval for an additional 17 Cannabis Strains from Colombian Agricultural Institute
Khiron has now secured all approvals required to commercialize current CBD cultivation and production for medical purposes. Khiron has now registered a total of 22 strains with Colombian Agricultural Institute ("ICA"). TORONTO , July 17, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a vertically integrated cannabis leader with core operations in Latin America , announced today that it has received approval from the National Cultivar Registry and the Technical Direction of the ICA for the commercialization of 17 stains of cannabis.
- Benzinga
Khiron Life Sciences To Participate At Cosmoprof North America
Khiron Life Sciences Corp. (TSXV: KHRN), (OTCQB: KHRNF ) announced Tuesday it will take part in Cosmoprof North America, a leading B2B beauty show in North America. The event will be held at the Mandalay ...
- PR Newswire
Khiron Targets Over 40,000 Beauty Industry Leaders with Kuida Skin Care Brand at Cosmoprof North America
Full portfolio of Kuida products will be exhibited at the event's Discover Beauty Pavilion to over 40,000 retail buyers, distributors, and beauty industry professionals Kuida is the first Colombian mass-market ...